Literature DB >> 26046372

Measuring resting energy expenditure during extracorporeal membrane oxygenation: preliminary clinical experience with a proposed theoretical model.

E De Waele1, K van Zwam2, S Mattens1, K Staessens2, M Diltoer1, P M Honoré1, J Czapla2, J Nijs2, M La Meir2, L Huyghens1, H Spapen1.   

Abstract

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is increasingly used in patients with severe respiratory failure. Indirect calorimetry (IC) is a safe and non-invasive method for measuring resting energy expenditure (REE). No data exist on the use of IC in ECMO-treated patients as oxygen uptake and carbon dioxide elimination are divided between mechanical ventilation and the artificial lung. We report our preliminary clinical experience with a theoretical model that derives REE from IC measurements obtained separately on the ventilator and on the artificial lung.
METHODS: A patient undergoing veno-venous ECMO for acute respiratory failure due to bilateral pneumonia was studied. The calorimeter was first connected to the ventilator and oxygen consumption (VO2 ) and carbon dioxide transport (VCO2 ) were measured until steady state was reached. Subsequently, the IC was connected to the membrane oxygenator and similar gas analysis was performed. VO2 and VCO2 values at the native and artificial lung were summed and incorporated in the Weir equation to obtain a REEcomposite .
RESULTS: At the ventilator level, VO2 and VCO2 were 29.5 ml/min and 16 ml/min. VO2 and VCO2 at the artificial lung level were 213 ml/min and 187 ml/min. Based on these values, a REEcomposite of 1703 kcal/day was obtained. The Faisy-Fagon and Harris-Benedict equations calculated a REE of 1373 and 1563 kcal/day.
CONCLUSION: We present IC-acquired gas analysis in ECMO patients. We propose to insert individually obtained IC measurements at the native and the artificial lung in the Weir equation for retrieving a measured REEcomposite .
© 2015 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26046372     DOI: 10.1111/aas.12564

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  6 in total

1.  A brief clinical case of monitoring of oxygenator performance and patient-machine interdependency during prolonged veno-venous extracorporeal membrane oxygenation.

Authors:  Mirko Belliato; Antonella Degani; Antonino Buffa; Fabio Sciutti; Michele Pagani; Carlo Pellegrini; Giorgio Antonio Iotti
Journal:  J Clin Monit Comput       Date:  2016-08-24       Impact factor: 2.502

2.  Resting Energy Expenditure of Patients on Venovenous Extracorporeal Membrane Oxygenation for Adult Respiratory Distress Syndrome: A Pilot Study.

Authors:  Chin Siang Ong; Patricia Brown; Benjamin L Shou; Christopher Wilcox; Sung-Min Cho; Pedro Alejandro Mendez-Tellez; Bo Soo Kim; Glenn J R Whitman
Journal:  Crit Care Explor       Date:  2022-07-18

Review 3.  Energy expenditure and indirect calorimetry in critical illness and convalescence: current evidence and practical considerations.

Authors:  Hanneke Pierre Franciscus Xaverius Moonen; Karin Josephina Hubertina Beckers; Arthur Raymond Hubert van Zanten
Journal:  J Intensive Care       Date:  2021-01-12

Review 4.  Methodological Aspects of Indirect Calorimetry in Patients with Sepsis-Possibilities and Limitations.

Authors:  Weronika Wasyluk; Agnieszka Zwolak; Joop Jonckheer; Elisabeth De Waele; Wojciech Dąbrowski
Journal:  Nutrients       Date:  2022-02-22       Impact factor: 5.717

Review 5.  Indirect Calorimetry in Clinical Practice.

Authors:  Marta Delsoglio; Najate Achamrah; Mette M Berger; Claude Pichard
Journal:  J Clin Med       Date:  2019-09-05       Impact factor: 4.241

6.  Gas exchange calculation may estimate changes in pulmonary blood flow during veno-arterial extracorporeal membrane oxygenation in a porcine model.

Authors:  Kaspar F Bachmann; Matthias Haenggi; Stephan M Jakob; Jukka Takala; Luciano Gattinoni; David Berger
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-04-15       Impact factor: 5.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.